HOBOKEN, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) — The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal first quarter ended September 30, 2025. “First quarter results met our expectations on the top- and bottom-line. During the quarter, organic net sales trends demonstrated sequential improvement in both our North America and International segments. Cost discipline and the decisive actions taken to streamline our cost structure drove a reduction in SG&A, and we are seeing early results from the execution against our ‘5 actions to win’, including benefits from pricing initiatives beginning to build,” said Alison Lewis, interim President and CEO.  Lewis continued,...

ROLLING MEADOWS, Ill., Nov. 07, 2025 (GLOBE NEWSWIRE) — RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”) (formerly known as Agrify Corporation), which delivers well-being to consumers through its portfolio of iconic licensed brands and hemp-derived THC products including Señorita THC Margaritas and RYTHM, today announced financial results for the quarter ended September 30, 2025.  Third Quarter 2025 Financial ResultsRevenue from continuing operations of $4.0 million, up 98% from $2.0 million in the prior quarter. $8.9 million operating loss from continuing operations. Cash balance of $35.6 million. Approximately 2.0 million shares, 7.6 million warrants outstanding and 6.2 million shares issuable upon conversion of outstanding convertible notes (excluding interest) as of September 30, 2025.Recent DevelopmentsThe Company’s...

All amounts in U.S. dollars unless otherwise stated TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter ended September 30, 2025. “Onex’ third quarter results reflect ongoing progress across the business,” said Bobby Le Blanc, CEO and President. “Our Private Equity teams continue to return meaningful capital to investors through strategic realizations, while planting the seeds for future growth through new investments. Our Credit team had another strong quarter bringing total capital raised or extended this year to more than $10 billion.”Financial Results (unaudited)($ millions except per share amounts) Three Months Ended Sept. 30 Nine Months Ended Sept. 30    2025 2024 2025 2024  Net earnings $ 39 $ 127 $ 436 $ 305  Net earnings per diluted...

Quarter Shows Company’s Continued Strong Financial Position and Momentum with its MS Clinical Trials and unbuzzd™ Recreational Beverage and Alcohol Metabolizer TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce its financial and operational results for the third quarter ending September 30, 2025. The Company remains in a strong financial position. A quarter-over-quarter comparison of Q3 2025 with Q2 2025 highlights a period of significant strengthening, with a 275% increase in shareholder equity, an 86% reduction in the debt-to-equity ratio, a 50% decrease in total liabilities, primarily due to the elimination of all liabilities associated with the previously issued convertible debentures, and an 8% reduction...

Financial Overview – Third QuarterRevenues of $165 Million, Down 41% From a Record a Year Ago Adjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.13; GAAP Diluted EPS of $0.08Financial Overview – Nine MonthsRevenues of $532 Million, Down 18% From a Record a Year Ago Adjusted Pre-Tax Income of $53 Million, GAAP Pre-Tax Income of $30 Million Adjusted EPS of $0.51; GAAP Diluted EPS of $0.37Talent InvestmentYear-to-Date Added Twelve Partners and Nine Managing Directors Two Additional Partners and Two Additional Managing Directors to Join Firm in Coming Months Closed Acquisition of Devon Park AdvisorsCapital ManagementStrong Balance Sheet with $186 Million of Cash and No Debt Year-to-Date Retired More Than Six Million Shares and Share Equivalents through Purchase, Exchange...

Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-year Purified Cortrophin® Gel net revenues of $101.9 million, an increase of 93.8% year-over-year Record quarterly adjusted non-GAAP EBITDA of $59.6 million, an increase of 69.8% year-over-year Diluted GAAP income per share of $1.13 and record adjusted non-GAAP diluted earnings per share of $2.04 Raised 2025 total net revenue guidance to $854.0 million to $873.0 million, adjusted non-GAAP EBITDA to $221.0 million to $228.0 million, and adjusted non-GAAP diluted earnings per share of $7.37 to $7.64 Rare Disease net revenues expected to represent approximately 50% of total Company net revenues in 2025, including revised guidance for:Purified Cortrophin Gel net revenues of $347.0 million to $352.0 million, representing year-over-year growth of 75% to 78%, and ILUVIEN(1)...

VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) announces its financial and operating results for the three and nine months ended September 30, 2025. All dollar amounts are in US dollars ($). “Endeavour Silver delivered a strong third quarter, highlighted by a significant increase in production and robust revenue growth,” commented Dan Dickson, Chief Executive Officer. “With silver equivalent production up 88% year-over-year and operating cash flow more than doubling, we continue to demonstrate the strength of our mining operations and our team’s commitment to operational excellence. With the recent achievement of commercial production at Terronera in October, we are excited about the Company’s future growth and the combined performance of...

Castellum, Inc. Reports Breakthrough Q3 2025 Results with First-Ever Positive Net IncomeCastellum, Inc. (NYSE-American: CTM) (“Castellum” or the “Company”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces its financial results for the third quarter ended September 30, 2025, featuring its first ever quarterly GAAP net income, improved operating performance, record cash, and as previously reported, further debt reduction – www.castellumus.comVIENNA, Va., Nov. 07, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (“Castellum” or the “Company”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces its financial results for the third quarter...

ATLANTA, Nov. 07, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray,” “Gray Media,” “we,” “us” or “our”) (NYSE: GTN) today announced its financial results for the quarter ended September 30, 2025. We are pleased to report that our total revenue, core advertising revenue, retransmission revenue, and political advertising revenue all were at or exceeded the high-end of our previously issued guidance ranges for the quarter. In addition, our expenses were below the low-end of our guidance ranges. The quarter also included the announcements of a historic station swap and three additional planned acquisitions of several leading television stations, as well as the multi-year renewal of our affiliation agreements with the FOX network. During the third quarter, we capitalized on strong market conditions by executing two separate debt market...

Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024. GAAP Operating Income was $1.5 million for Q3 2025 versus $2.0 million in Q3 2024. Q3 2025 included stock-based compensation costs of $1.4 million versus $0 in Q3 2024. Company provides guidance for revenues of $13-$14 million for Q4 2025. EDEN PRAIRIE, Minn., Nov. 07, 2025 (GLOBE NEWSWIRE) — Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial results for the three months ended September 30, 2025. Quarter ended September 30, 2025Revenue for the three months ended September 30, 2025, totaled...